OBJECTIVE
To study the effect of methylprednisolone (MP) and cyclophosphamide (CPA) intermittent intravenous pulse therapy and the clinical prognosis in children with severe juvenile onset systemic lupus erythematosus (JOSLE).
METHODS
Thirty patients with JOSLE, diagnosed by clinical, laboratory or